http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0760669-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_91c97630904e645527c3ae79303e1fc1 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-30 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-30 |
| filingDate | 1995-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50b40636accffd8e94a0ad4284cefd06 |
| publicationDate | 1997-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0760669-A1 |
| titleOfInvention | Antiasthmatic preparation |
| abstract | The problem solved by the present invention is the creation of an antiasthmatic remedy breaking of the disease fits and leading to full healing. The substance of the decision lies in the combination of active components and their proportion: atropine sulphate 0,25 - 1,00 mg; papaverine hydrochloride 30,00-200,00 mg; caffeine purum 30,00-250,00 mg; ergotamine tartrate 0,25-2,00 mg; zinc sulphate 10,00-220,00 mg; sex hormones 0,25-1,00 mg, the sex hormones being diethylstilbestrol propionate or methandrostenol. The advantages of the composition are that it leads to stopping the asthmatic fits for 30-40 min, averts any new fits, and leads in practice to full healing. |
| priorityDate | 1994-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 52.